ANNOUNCEMENT: McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
July 28, 2011: McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, announced today that it will lower the recommended dose of extra strength Tylenol and Regular Strength Tylenol. This is a substantial change for a product that for the last 30 years has marketed itself as: “the painkiller you can trust” and “the painkiller doctors prescribe most.” If these marketing statements were true, then why does the company feel now that it should lower the recommended dose?
The truth is, this change is part of what our Tylenol team has been fighting for over the last decade – an admission by the manufacturer of Tylenol that the product is in fact extremely dangerous and that too many people are dying and suffering liver damage as a result of acetaminophen poisoning. This change is important for consumers who have been injured by acetaminophen and they are advised to seek a knowledgeable attorney in this area. Henry Spiegel Milling is paving the way in this regard.
For more information on this announcement, click here.
